CCAT2 promoted the migration and invasion of ESCC cells in vitro, and tumorigenesis in vivo by upregulating TK1 expression, while overexpression of miR-200b reversed these effects of CCAT2. The gene discussed is CCAT2; the disease is esophageal squamous cell carcinoma.